Search - tctmd.com

Displaying 781 - 800 of 2954

Sort: Relevancy | Date

Presentation TCT 2019

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Presenter: Robert de Winter

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Presenter: Sripal Bangalore

September 26, 2019

Presentation TCT 2019

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Presenter: Greg Kaluza

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

Circumstances in Which I Feel That I Have to Use DCB/DES

Presenter: Ehrin Armstrong

September 26, 2019

Presentation TCT 2019

There Are No Circumstances in Which I Have to Use DCB/DES

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Presenter: Robert Byrne

September 26, 2019

Presentation TCT 2019

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

Featured Technological Trends: Mitral, Tricuspid, and Other SHD Technologies - Saturn TMVR: Novel Design Benefits, Implant Procedure, and Preclinical Outcomes

Presentation TCT 2019

Saturn TMVR: Novel Design Benefits, Implant Procedure, and Preclinical Outcomes

Presenter: Paolo Denti

September 25, 2019

Presentation TCT 2019

TCT 92: Antegrade LAMPOON (Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction): A Novel Modification of the Previously Described Retrograde LAMPOON, is a Technically Feasible, Reproducible, Effective and…

Presenter: Adam Greenbaum

September 25, 2019

Aortic Valve Intervention and Ancillary Solutions II - A Novel-Designed, Temporary Disposable Pacing Catheter That Can Be Deployed Swiftly to Sense and Pace the Atrium and Ventricle in Dual Chamber Synchrony

Presentation TCT 2019

A Novel-Designed, Temporary Disposable Pacing Catheter That Can Be Deployed Swiftly to Sense and Pace the Atrium and Ventricle in Dual Chamber Synchrony

Presenter: Christian Marin y Kall

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Advertisement

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Polymer-Free DES: Lessons Learned From Recent Trials

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Circumstances in Which I Feel That I Have to Use DCB/DES

There Are No Circumstances in Which I Have to Use DCB/DES

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Potential Hazards of Re-Stenting

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Saturn TMVR: Novel Design Benefits, Implant Procedure, and Preclinical Outcomes

TCT 92: Antegrade LAMPOON (Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction): A Novel Modification of the Previously Described Retrograde LAMPOON, is a Technically Feasible, Reproducible, Effective and…

A Novel-Designed, Temporary Disposable Pacing Catheter That Can Be Deployed Swiftly to Sense and Pace the Atrium and Ventricle in Dual Chamber Synchrony

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content